These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2007-002328-14 A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multi-center, International Study to Evaluate the Efficacy and Safety of Oxabact(TM) to Reduce Urinary Oxalate in Subjects with Primary Hype... 2008-09-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-006187-30 An Open-label (OL) Extension Study evaluating the Long-Term Safety of OxabactTM in Subjects with Primary Hyperoxaluria (PH) who participated in the Double-Blind (DB) Efficacy Study 2009-03-27 bad-data
Reported results 2009-015817-31 A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multi-center, Study to Evaluate the Efficacy and Safety of Oxabact(TM) to Reduce Urinary Oxalate in Subjects with Primary Hyperoxaluria 2011-01-14 due-trials
Exempt, with results 2012-005606-22 A Phase 1/2, randomised, placebo-controlled, double-blind, multi-centre study to evaluate the efficacy and safety of OC5 to reduce urinary oxalate in subjects with primary hyperoxaluria 2015-01-23 not-yet-due
Ongoing 2013-004368-74 A phase 2 open-label multi-centre study to evaluate the efficacy and safety of Oxabact® to reduce plasma oxalate in patients with primary hyperoxaluria who are on dialysis not-yet-due
Other 2017-000684-33 A phase III double-blind, randomised study to evaluate the long-term efficacy and safety of Oxabact® in patients with primary hyperoxaluria not-yet-due
Ongoing 2018-003576-12 An open-label single-arm treatment extension study to evaluate the long- term efficacy and safety of Oxabact® for patients with primary hyperoxaluria who completed study OC5-DB-02 not-yet-due